Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
Completed
- Conditions
- Corpus Uteri Carcinoma
- Registration Number
- NCT01650987
- Lead Sponsor
- Centre Oscar Lambret
- Brief Summary
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment
- Detailed Description
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment on sexual function after treatment (radiotherapy and/or surgery)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 72
Inclusion Criteria
- Patients whose treatment is provided to Centre Oscar Lambret
- With a corpus uteri adenocarcinoma, no metastatic, treated by:
- Surgery and observation without complementary treatment
- Or surgery and adjuvant radiotherapy
- Or Surgery and curietherapy of vaginal dome
- With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
- External radiochemotherapy and curietherapy
- Or only surgery
- Or pre-surgical curietherapy and surgery
- Age > 18 years
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Toxicities including on sexual function up to 3 years According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary
- Secondary Outcome Measures
Name Time Method Compare the various scales of toxicity up to 3 years Compare the various scales of toxicity
Study the sexual behavior modifications up to 3 years According to a questionnaire and a personal discussion
Specify correlation modifications of sexual behavior up to 3 years Specify the existence of a correlation between toxicities included modifications and sexual behavior modifications
Trial Locations
- Locations (1)
Centre Oscar Lambret
🇫🇷Lille, France